- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
CA.3: 5 residues within 4Å:- Chain A: D.293, T.297, D.324, G.344, G.346
6 PLIP interactions:5 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.293, A:T.297, A:D.324, A:G.344, A:G.346, H2O.10
CA.17: 5 residues within 4Å:- Chain B: D.293, T.297, D.324, G.344, G.346
6 PLIP interactions:5 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.293, B:T.297, B:D.324, B:G.344, B:G.346, H2O.23
CA.28: 5 residues within 4Å:- Chain C: D.293, T.297, D.324, G.344, G.346
6 PLIP interactions:5 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.293, C:T.297, C:D.324, C:G.344, C:G.346, H2O.37
CA.42: 5 residues within 4Å:- Chain D: D.293, T.297, D.324, G.344, G.346
6 PLIP interactions:5 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.293, D:T.297, D:D.324, D:G.344, D:G.346, H2O.50
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 1 residues within 4Å:- Chain A: N.144
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.144
NAG.18: 2 residues within 4Å:- Chain B: N.144, G.145
No protein-ligand interaction detected (PLIP)NAG.29: 1 residues within 4Å:- Chain C: N.144
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.144
NAG.43: 2 residues within 4Å:- Chain D: N.144, G.145
No protein-ligand interaction detected (PLIP)- 4 x G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid(Non-covalent)
G39.5: 14 residues within 4Å:- Chain A: R.116, E.117, D.149, R.150, W.177, L.221, A.245, E.275, E.276, R.292, N.294, R.374, Y.409
- Ligands: EDO.15
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:W.177, A:L.221, A:A.245
- Hydrogen bonds: A:E.117, A:R.150, A:Y.409
- Water bridges: A:D.149, A:D.149, A:R.154, A:E.276, A:R.374, A:R.374
- Salt bridges: A:R.116, A:R.292, A:R.374
G39.19: 13 residues within 4Å:- Chain B: R.116, E.117, D.149, R.150, W.177, L.221, A.245, E.275, E.276, R.292, N.294, R.374, Y.409
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:W.177, B:L.221, B:A.245
- Hydrogen bonds: B:E.117, B:R.150, B:Y.409
- Water bridges: B:R.154, B:E.276
- Salt bridges: B:R.116, B:R.292, B:R.374
G39.30: 14 residues within 4Å:- Chain C: R.116, E.117, D.149, R.150, W.177, L.221, A.245, E.275, E.276, R.292, N.294, R.374, Y.409
- Ligands: EDO.40
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:W.177, C:L.221, C:A.245
- Hydrogen bonds: C:E.117, C:R.150
- Water bridges: C:R.154, C:E.276, C:R.374, C:R.374
- Salt bridges: C:R.116, C:R.292, C:R.374
G39.44: 13 residues within 4Å:- Chain D: R.116, E.117, D.149, R.150, W.177, L.221, A.245, E.275, E.276, R.292, N.294, R.374, Y.409
11 PLIP interactions:11 interactions with chain D- Hydrophobic interactions: D:W.177, D:L.221, D:A.245
- Hydrogen bonds: D:E.117, D:R.150
- Water bridges: D:R.154, D:E.276, D:E.276
- Salt bridges: D:R.116, D:R.292, D:R.374
- 34 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 6 residues within 4Å:- Chain A: S.90, T.91, V.381, S.397, G.452, Q.453
Ligand excluded by PLIPEDO.7: 9 residues within 4Å:- Chain A: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
- Chain B: E.208
Ligand excluded by PLIPEDO.8: 8 residues within 4Å:- Chain A: H.134, Y.142, N.144, G.145, T.146, N.151, L.153
- Chain D: R.102
Ligand excluded by PLIPEDO.9: 9 residues within 4Å:- Chain A: E.208
- Chain D: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
Ligand excluded by PLIPEDO.10: 2 residues within 4Å:- Chain A: R.252, F.266
Ligand excluded by PLIPEDO.11: 2 residues within 4Å:- Chain A: I.261, I.262
Ligand excluded by PLIPEDO.12: 2 residues within 4Å:- Chain A: D.342, K.343
Ligand excluded by PLIPEDO.13: 4 residues within 4Å:- Chain A: R.147, D.432, G.433, G.434
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain A: V.248, K.272, Y.296
Ligand excluded by PLIPEDO.15: 7 residues within 4Å:- Chain A: R.116, R.147, G.148, D.149, W.408, H.439
- Ligands: G39.5
Ligand excluded by PLIPEDO.16: 1 residues within 4Å:- Chain A: F.266
Ligand excluded by PLIPEDO.20: 7 residues within 4Å:- Chain A: K.160
- Chain B: I.171, H.173, Y.190, K.205, G.207, E.208
Ligand excluded by PLIPEDO.21: 8 residues within 4Å:- Chain A: R.102
- Chain B: H.134, Y.142, N.144, G.145, T.146, N.151, L.153
Ligand excluded by PLIPEDO.22: 4 residues within 4Å:- Chain B: P.88, E.419, C.420
- Chain C: R.260
Ligand excluded by PLIPEDO.23: 3 residues within 4Å:- Chain B: S.90, S.451, G.452
Ligand excluded by PLIPEDO.24: 7 residues within 4Å:- Chain B: S.90, T.91, W.364, V.381, S.397, G.452, Q.453
Ligand excluded by PLIPEDO.25: 3 residues within 4Å:- Chain B: D.320, D.392, A.393
Ligand excluded by PLIPEDO.31: 6 residues within 4Å:- Chain C: S.90, T.91, V.381, S.397, G.452, Q.453
Ligand excluded by PLIPEDO.32: 9 residues within 4Å:- Chain C: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
- Chain D: E.208
Ligand excluded by PLIPEDO.33: 8 residues within 4Å:- Chain B: R.102
- Chain C: H.134, Y.142, N.144, G.145, T.146, N.151, L.153
Ligand excluded by PLIPEDO.34: 9 residues within 4Å:- Chain B: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
- Chain C: E.208
Ligand excluded by PLIPEDO.35: 2 residues within 4Å:- Chain C: R.252, F.266
Ligand excluded by PLIPEDO.36: 2 residues within 4Å:- Chain C: I.261, I.262
Ligand excluded by PLIPEDO.37: 2 residues within 4Å:- Chain C: D.342, K.343
Ligand excluded by PLIPEDO.38: 4 residues within 4Å:- Chain C: R.147, D.432, G.433, G.434
Ligand excluded by PLIPEDO.39: 3 residues within 4Å:- Chain C: V.248, K.272, Y.296
Ligand excluded by PLIPEDO.40: 7 residues within 4Å:- Chain C: R.116, R.147, G.148, D.149, W.408, H.439
- Ligands: G39.30
Ligand excluded by PLIPEDO.41: 1 residues within 4Å:- Chain C: F.266
Ligand excluded by PLIPEDO.45: 7 residues within 4Å:- Chain C: K.160
- Chain D: I.171, H.173, Y.190, K.205, G.207, E.208
Ligand excluded by PLIPEDO.46: 8 residues within 4Å:- Chain C: R.102
- Chain D: H.134, Y.142, N.144, G.145, T.146, N.151, L.153
Ligand excluded by PLIPEDO.47: 4 residues within 4Å:- Chain A: R.260
- Chain D: P.88, E.419, C.420
Ligand excluded by PLIPEDO.48: 3 residues within 4Å:- Chain D: S.90, S.451, G.452
Ligand excluded by PLIPEDO.49: 7 residues within 4Å:- Chain D: S.90, T.91, W.364, V.381, S.397, G.452, Q.453
Ligand excluded by PLIPEDO.50: 3 residues within 4Å:- Chain D: D.320, D.392, A.393
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escuret, V. et al., A Novel I221 L Substitution in Neuraminidase Confers High Level Resistance to Oseltamivir in Influenza B Viruses. J.Infect.Dis. (2014)
- Release Date
- 2014-05-14
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid(Non-covalent)
- 34 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escuret, V. et al., A Novel I221 L Substitution in Neuraminidase Confers High Level Resistance to Oseltamivir in Influenza B Viruses. J.Infect.Dis. (2014)
- Release Date
- 2014-05-14
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B